|
1
|
Hastings MC, Moldoveanu Z, Suzuki H,
Berthoux F, Julian BA, Sanders JT, Renfrow MB, Novak J and Wyatt
RJ: Biomarkers in IgA nephropathy: relationship to pathogenetic
hits. Expert Opin Med Diagn. 7:615–627. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aizawa M, Suzuki Y, Suzuki H, Pang H,
Kihara M, Nakata J, Yamaji K, Horikoshi S and Tomino Y: Uncoupling
of glomerular IgA deposition and disease progression in
alymphoplasia mice with IgA nephropathy. PLoS One. 9:e953652014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki Y, Suzuki H, Nakata J, Sato D,
Kajiyama T, Watanabe T and Tomino Y: Pathological role of tonsillar
B cells in IgA nephropathy. Clin Dev Immunol. 2011:6390742011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kiryluk K and Novak J: The genetics and
immunobiology of IgA nephropathy. J Clin Invest. 124:2325–2332.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu SJ, Gu Y, Li SJ, et al:
Nephroprotective effects of piperazine ferulate on rat remnant
kidney. Chin J Integr Trad West Nephrol. 3:256–259. 2002.
|
|
6
|
Yuzawa Y, Yamamoto R, Takahashi K,
Katafuchi R, Tomita M, Fujigaki Y, Kitamura H, Goto M, Yasuda T,
Sato M, Urushihara M, Kondo S, Kagami S, Yasuda Y, Komatsu H,
Takahara M, Harabuchi Y, Kimura K and Matsuo S: Evidence-based
clinical practice guidelines for IgA nephropathy 2014. Clin Exp
Nephrol. April 21st–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalantari S, Rutishauser D, Samavat S,
Nafar M, Mahmudieh L, Rezaei-Tavirani M and Zubarev RA: Urinary
prognostic biomarkers and classification of IgA nephropathy by high
resolution mass spectrometry coupled with liquid chromatography.
PLoS One. 8:e808302013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lai KN, Chan LY, Tang SC, Tsang AW, Guo H,
Tse KC, Yip T and Leung JC: Characteristics of polymeric lambda-IgA
binding to leukocytes in IgA nephropathy. J Am Soc Nephrol.
13:2309–2319. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leung JC, Tsang AW, Chan DT and Lai KN:
Absence of CD89, polymeric immunoglobulin receptor, and
asialoglycoprotein receptor on human mesangial cells. J Am Soc
Nephrol. 11:241–249. 2000.PubMed/NCBI
|
|
10
|
Zhang J, Chen J, Yang J, Xu C, Ding J,
Yang J, Guo Q, Hu Q and Jiang H: Sodium ferulate inhibits
neointimal hyperplasia in rat balloon injury model. PLoS One.
9:e875612014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang W, Pei X, Xu M, Sun S, Zhang C, Mu K
and Liu Z: The protective effect of sodium ferulate and oxymatrine
combination on paraquat-induced lung injury. Iran J Pharm Res.
14:573–583. 2015.PubMed/NCBI
|
|
12
|
Qin J, Shang L, Ping AS, Li J, Li XJ, Yu
H, Magdalou J, Chen LB and Wang H: TNF/TNFR signal transduction
pathway-mediated anti-apoptosis and anti-inflammatory effects of
sodium ferulate on IL-1β-induced rat osteoarthritis chondrocytes in
vitro. Arthritis Res Ther. 14:R2422012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu H, Fan W, Fu P, Zuo C, Feng P, Liu F,
Zhou L, Chen F, Zhong H, Liang Y and Shi M: General acteoside of
Rehmanniae leaves in the treatment of primary chronic
glomerulonephritis: A randomized controlled trial. Afr J Tradit
Complement Altern Med. 10:109–115. 2013.PubMed/NCBI
|
|
14
|
Tyagi AK, Bukvicki D, Gottardi D,
Tabanelli G, Montanari C, Malik A and Guerzoni ME: Eucalyptus
essential oil as a natural food preservative: in vivo and in vitro
antiyeast potential. Biomed Res Int. 2014:9691432014.PubMed/NCBI
|
|
15
|
Dhibi S, Mbarki S, Elfeki A and Hfaiedh N:
Eucalyptus globulus extract protects upon
acetaminophen-induced kidney damages in male rat. Bosn J Basic Med
Sci. 14:99–104. 2014.PubMed/NCBI
|
|
16
|
Bokaeian M, Nakhaee A, Moodi B and Ali
Khazaei H: Eucalyptus globulus (eucalyptus) treatment of
candidiasis in normal and diabetic rats. Iran Biomed J. 14:121–126.
2010.PubMed/NCBI
|
